Blog

Full QA/RA team or singular expert – What’s right for you?

Project timeline:
months
Service areas:
Quality and Regulatory
Written by
Teija Tulinen
Innokas content creator
Innokas employee on a laptop with accompanied by "Innokas sustainability report 2024" title

Photo features some of our very own QA/RA experts; Emi Iizuka, Minna Eskola and Parisa Farzanehkari, who all bring their unique expertise to a comprehensive approach that delivers well-informed, nuanced support where it matters most.

Whether you're a startup or a scale-up, Quality Assurance (QA) and Regulatory Affairs (RA) expertise is essential for the safety, credibility, and market success of regulated products. With the right guidance, you can stay focused on innovation while ensuring compliance, minimizing risks, and accelerating your path to market. How do you know what scale of support you should seek? Should you engage a full QA/RA team, or will a single expert suffice? Let’s explore.

Key factors to consider when seeking QA/RA expertise

1. Product complexity

If your product involves advanced technologies, such as AI, software as a medical device (SaMD), or hardware with strict safety standards, a full QA/RA team may be necessary. A multidisciplinary team brings diverse perspectives and deep expertise across areas like:

• Usability and clinical evaluation

• Biocompatibility and risk management

• Cybersecurity and AI compliance

For example, Innokas’ QA/RA team includes specialists in each of these domains to ensure comprehensive oversight from concept to CE marking.

2. Regulatory environment

European Medtech sector operates within a highly regulated EU framework. While a single expert might suffice for straightforward products, complex regulatory pathways, often under MDR, require a team approach. A full-service partner can also adapt their certified Quality Management System (QMS) to your needs, which is especially valuable if you're starting without one.

3. Company resources

Startups and small teams may lean toward hiring a singular expert or fractional support. However, as your portfolio grows, a scalable QA/RA partner offers the flexibility and depth needed to support expansion. Larger companies benefit from faster turnaround times and broader coverage with a full team.

4. Stage of development

Early-stage companies often begin with foundational QA/RA support. As development progresses, transitioning to a full team ensures readiness for audits, clinical evaluations, and market entry. If your partner also offers product development and manufacturing capabilities, you gain a one-stop-shop to bring your device to market with significantly reduced internal workload.

Strategic collaboration drives success

Ultimately, the choice between a full QA/RA team and a singular expert depends on your product, goals, and growth trajectory. Both models offer value, but the right partner will help you navigate regulatory complexity with confidence.

In the European medtech landscape, where innovation meets strict compliance, outsourcing QA/RA to a trusted partner is a strategic investment. It’s not solely about meeting requirements; it’s about accelerating innovation, reducing risk, and staying competitive.

Whether you're launching a new device or scaling your portfolio, choosing the right QA/RA support can make all the difference. If you're exploring outsourced expertise, let's discuss how a tailored partnership can help bring your innovation to market faster and safer.

Contact us

Editors

Sandra Hänninen

QA/RA specialist

sandra.hanninen@innokas.eu

Parisa Farzanehkari

Clinical affairs specialist

parisa.farzanehkari@innokas.eu

Emi Iizuka

Clinical affairs specialist

emi.iizuka@innokas.eu

Lead Magnet: The 101 of medical technology innovation
Download

Ask more about this project

Innokas highlights

Here you can find more of our latest news and insights in this category.

Innokas acquires AQAP certification

Read more

Growth, sustainability, and quality partnerships 

Read more

Innokas to extend its presence into defence and dual-use industry

Read more

Innokas announces strategic business transfer with MEGIN

Read more

Innokas highlights

Here you can find more of our latest news, tips and insights.

Full QA/RA team or singular expert – What’s right for you?

Read more

Slush 2025 – A first-timer’s perspective on innovation and opportunity

Read more

What happens when a medical device has no particular standard?

Read more

IEC 60601-1 – The cornerstone of electrical medical device safety

Read more

Innokas highlights

Here you can find more of our latest news and insights.

Case Terveystalo – Innokas software team helps develop medical software expertise

Read more

Case Nexstim – Familiarity with the sector and flexible operation gives a competitive edge

Read more

Case UKK Terveyspalvelut – Problem-solving skills and customer-oriented operation

Read more

Case MEGIN – Functional brain mapping by solutions based on magnetoencephalography technology

Read more

Innokas highlights

Here you can find more of our insights, news and tips.

Reflections from Alihankinta – Is competitive sustainability gaining ground?

Read more

Inspiring autumn afternoon seminar in Oslo

Read more

No one builds alone – Contract manufacturing took the spotlight at Alihankinta subcontracting fair

Read more

Innokas challenges design thinkers to integrate circular design in healthcare

Read more

Innokas highlights

Here you can find more of our insights, news and tips.

Building bridges – Marcus von Schoultz joins the Innokas team

Read more

Solutions for sale – Mostafa is a new sales representative at Innokas

Read more

A summer at Innokas – Jenna Salmela’s path toward an IT career

Read more

Learning through circuits for thirty years – Marko’s Journey in medical electronics

Read more
Siberian husky sled running in a snowy environment. Innokas brand green glass theme. Background.

Let's get started!

Contact us and find out what we can do for you.

Contact us